129 related articles for article (PubMed ID: 29676376)
1. An unusual presentation of large B-cell lymphoma with interferon regulatory factor 4 gene rearrangement.
Verma A; Epari S; Gujral S; Shet T
Indian J Pathol Microbiol; 2018; 61(2):271-274. PubMed ID: 29676376
[TBL] [Abstract][Full Text] [Related]
2. [Diagnosis and differential diagnosis of large B-cell lymphoma with IRF4 rearrangement].
Luo D; Xiang CX; Ma DS; Liu GZ; Fan MT; Wang YB; Zhao J; Yuan YQ; Shen QQ; Liu XY; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):563-569. PubMed ID: 38825901
[No Abstract] [Full Text] [Related]
3. IRF4 translocation status in pediatric follicular and diffuse large B-cell lymphoma patients enrolled in Children's Oncology Group trials.
Chisholm KM; Mohlman J; Liew M; Termuhlen A; Cairo MS; Gross TG; Perkins SL; Miles RR
Pediatr Blood Cancer; 2019 Aug; 66(8):e27770. PubMed ID: 31012208
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
5. Analysis of clinical and immunophenotypic features along with treatment outcomes of diffuse large B cell lymphoma patients, based on the involvement of nodal or extranodal primary sites.
Wang C; Li W; Liu C; He H; Bai O
Blood Cells Mol Dis; 2016 Mar; 57():42-9. PubMed ID: 26852654
[TBL] [Abstract][Full Text] [Related]
6. [Significance of myc gene rearrangement and its correlation with prognosis in diffuse large B cell lymphoma].
Zhang HW; Chen ZW; He JX; Zheng YP; Han WE; Zhao ZQ; Bai W; Wang JF
Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):119-23. PubMed ID: 23714666
[TBL] [Abstract][Full Text] [Related]
7. [Diffuse large B-cell lymphoma of testis: a clinicopathologic and immunophenotypic study of 58 cases].
Yang ZR; Bi CF; Zhang WY; Yang QP; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2013 Sep; 42(9):589-92. PubMed ID: 24314243
[TBL] [Abstract][Full Text] [Related]
8. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
[TBL] [Abstract][Full Text] [Related]
9. [Nodal versus extranodal diffuse large B-cell lymphoma: comparison of clinicopathologic features, immunophenotype and prognosis].
Lu JB; Li XQ; Zhang PH; Zhou XY; Zhang TM; Li XM; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):470-3. PubMed ID: 17845761
[TBL] [Abstract][Full Text] [Related]
10. [Gene expression profiling of diffuse large B-cell lymphoma in China].
Liu YH; Li L; Liu G; Zhuang HG; Luo DL; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):79-83. PubMed ID: 17493379
[TBL] [Abstract][Full Text] [Related]
11. [Primary gastrointestinal diffuse large B-cell lymphoma: an immunohistochemical and prognostic study of 90 cases].
Lin L; Min M; Bi CF; Wang XQ; Luo TY; Zhao S; Zhang WY; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):220-6. PubMed ID: 21615994
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of bcl-6 protein expression and gene rearrangement in diffuse large B-cell lymphoma].
Min DL; Xia HL; Zhou XY; Sun MH; Yang WT; Zhang TM; Zheng AH; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):327-31. PubMed ID: 16185497
[TBL] [Abstract][Full Text] [Related]
13. CD10, BCL6, and MUM1 expression in diffuse large B-cell lymphoma on FNA samples.
Cozzolino I; Varone V; Picardi M; Baldi C; Memoli D; Ciancia G; Selleri C; De Rosa G; Vetrani A; Zeppa P
Cancer Cytopathol; 2016 Feb; 124(2):135-43. PubMed ID: 26414904
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical and biological prognostic factors in relapsed or refractory diffuse large B-cell lymphoma patients after previous treatment with rituximab and chemotherapy: results of the PRO-R-IPI study.
Panizo C; Rodríguez AJ; Gutiérrez G; Díaz FJ; González-Barca E; de Oña R; Grande C; Sancho JM; García-Álvarez MF; Sánchez-González B; Peñalver FJ; Cannata J; Espeso M; Requena MJ; Gardella S; Durán S; González AP; Alfonso A; Caballero MD;
Clin Lymphoma Myeloma Leuk; 2015 Jul; 15(7):398-403. PubMed ID: 25843416
[TBL] [Abstract][Full Text] [Related]
15. [Subgrouping and outcome prediction of diffuse large B-cell lymphoma by immunohistochemistry].
Ye ZY; Cao YB; Lin TY; Lin HL
Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):654-9. PubMed ID: 18194597
[TBL] [Abstract][Full Text] [Related]
16. B cell lymphoma with IRF4 rearrangement: A clinicopathological study of 13 cases.
Zhou L; Gu B; Shen X; Binshen O; Dong L; Zhou J; Yi H; Wang C
Pathol Int; 2021 Mar; 71(3):183-190. PubMed ID: 33503299
[TBL] [Abstract][Full Text] [Related]
17. A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.
Jarosova M; Kriegova E; Schneiderova P; Fillerova R; Prochazka V; Mikesova M; Flodr P; Indrak K; Papajik T
Pathol Oncol Res; 2016 Apr; 22(2):233-43. PubMed ID: 26319027
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic significance of bcl-6 gene rearrangement and expression in three molecular subgroups of diffuse large B-cell lymphoma].
Xu FP; Liu YH; Luo XL; Zhuang HG; Li L; Luo DL; Xu J; Zhang F; Zhang MH; Du X; Li WY
Zhonghua Bing Li Xue Za Zhi; 2008 Jun; 37(6):371-6. PubMed ID: 19031715
[TBL] [Abstract][Full Text] [Related]
19. The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression.
Lossos IS
Cancer Cell; 2007 Sep; 12(3):189-91. PubMed ID: 17785200
[TBL] [Abstract][Full Text] [Related]
20.
Büyüktaş D; Örnek S; Tokat F; Tecimer T; Ferhanoğlu B
Turk J Haematol; 2020 Nov; 37(4):292-294. PubMed ID: 32349466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
